Tower Research Capital (TRC)’s ImageneBio, Inc. Common Stock IMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.05K | Buy |
+190
| New | +$3.05K | ﹤0.01% | 4560 |
|
2025
Q1 | – | Sell |
-303
| Closed | -$5.96K | – | 5480 |
|
2024
Q4 | $5.96K | Buy |
303
+147
| +94% | +$2.89K | ﹤0.01% | 4219 |
|
2024
Q3 | $3.24K | Sell |
156
-1,522
| -91% | -$31.7K | ﹤0.01% | 4877 |
|
2024
Q2 | $33.2K | Buy |
1,678
+934
| +126% | +$18.5K | ﹤0.01% | 3409 |
|
2024
Q1 | $12.7K | Buy |
744
+328
| +79% | +$5.59K | ﹤0.01% | 3457 |
|
2023
Q4 | $9.84K | Buy |
416
+107
| +35% | +$2.53K | ﹤0.01% | 4339 |
|
2023
Q3 | $16.1K | Buy |
309
+233
| +307% | +$12.1K | ﹤0.01% | 3574 |
|
2023
Q2 | $6.01K | Sell |
76
-221
| -74% | -$17.5K | ﹤0.01% | 4728 |
|
2023
Q1 | $13K | Sell |
297
-863
| -74% | -$37.8K | ﹤0.01% | 3975 |
|
2022
Q4 | $37K | Buy |
1,160
+840
| +263% | +$26.8K | ﹤0.01% | 2565 |
|
2022
Q3 | $13K | Buy |
320
+56
| +21% | +$2.28K | ﹤0.01% | 4271 |
|
2022
Q2 | $14K | Buy |
264
+114
| +76% | +$6.05K | ﹤0.01% | 4141 |
|
2022
Q1 | $11K | Buy |
150
+4
| +3% | +$293 | ﹤0.01% | 4177 |
|
2021
Q4 | $22K | Buy |
146
+84
| +135% | +$12.7K | ﹤0.01% | 3563 |
|
2021
Q3 | $9K | Sell |
62
-40
| -39% | -$5.81K | ﹤0.01% | 4441 |
|
2021
Q2 | $17K | Buy |
+102
| New | +$17K | ﹤0.01% | 4043 |
|